Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open-label Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)

NCT01278173 is registered in ClinicalTrials.gov with Lundbeck LLC as lead sponsor.

NCT NCT01278173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01278173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open-label Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)
Lead sponsor
Lundbeck LLC
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2010
Completion date
May 31, 2015
Enrollment
65 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

adult refractory complex partial seizures